Exagen (XGN) Short Interest Ratio & Short Volume $6.02 -0.12 (-1.95%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$6.02 0.00 (-0.08%) As of 05/2/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Exagen Short Interest DataExagen (XGN) has a short interest of 60,800 shares, representing 0.66% of the float (the number of shares available for trading by the public). This marks a 31.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 93,686 shares to cover all short positions.Current Short Interest60,800 sharesPrevious Short Interest46,200 sharesChange Vs. Previous Month+31.60%Dollar Volume Sold Short$268,128.00Short Interest Ratio0.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares17,898,000 sharesFloat Size9,170,000 sharesShort Percent of Float0.66%Today's Trading Volume164,133 sharesAverage Trading Volume93,686 sharesToday's Volume Vs. Average175% Short Selling Exagen? Sign up to receive the latest short interest report for Exagen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXGN Short Interest Over TimeXGN Days to Cover Over TimeXGN Percentage of Float Shorted Over Time Exagen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202560,800 shares $268,128.00 +31.6%0.7%0.5 $4.41 3/31/202546,200 shares $165,858.00 +162.5%0.5%0.3 $3.59 3/15/202517,600 shares $62,656.00 -23.5%0.2%0.1 $3.56 2/28/202523,000 shares $79,580.00 -29.2%0.3%0.1 $3.46 2/15/202532,500 shares $137,475.00 +21.7%0.4%0.2 $4.23 1/31/202526,700 shares $106,800.00 +260.8%0.3%0.2 $4.00 1/15/20257,400 shares $23,088.00 -90.7%0.1%0.1 $3.12 12/31/202479,200 shares $324,720.00 +1.4%0.9%0.7 $4.10 12/15/202478,100 shares $451,027.50 +36.5%0.9%1 $5.78 11/30/202457,200 shares $227,084.00 -9.1%0.7%1.2 $3.97 Get the Latest News and Ratings for XGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exagen and its competitors with MarketBeat's FREE daily newsletter. 11/15/202462,900 shares $187,442.00 +20.5%0.8%1.4 $2.98 10/31/202452,200 shares $126,846.00 +122.1%0.6%1.4 $2.43 10/15/202423,500 shares $63,450.00 +48.7%0.3%0.4 $2.70 9/30/202415,800 shares $48,822.00 -6.0%0.2%0.3 $3.09 9/15/202416,800 shares $49,728.00 +20.9%0.2%0.3 $2.96 8/31/202413,900 shares $41,422.00 -12.0%0.2%0.3 $2.98 8/15/202415,800 shares $44,714.00 -41.5%0.2%0.3 $2.83 7/31/202427,000 shares $52,650.00 -7.2%0.3%0.5 $1.95 7/15/202429,100 shares $57,618.00 -22.2%0.3%0.8 $1.98 6/30/202437,400 shares $68,068.00 +67.7%0.4%1.1 $1.82 6/15/202422,300 shares $43,708.00 -7.5%0.3%0.6 $1.96 5/31/202424,100 shares $46,995.00 -14.8%0.3%0.5 $1.95 5/15/202428,300 shares $54,053.00 +573.8%0.3%0.6 $1.91 4/30/20244,200 shares $5,754.00 -64.7%0.1%0.1 $1.37 4/15/202411,900 shares $17,017.00 -42.0%0.2%0.3 $1.43 3/31/202420,500 shares $32,595.00 +294.2%0.3%0.5 $1.59 3/15/20245,200 shares $8,424.00 +20.9%0.1%0.1 $1.62 2/29/20244,300 shares $9,675.00 -35.8%0.1%0.1 $2.25 2/15/20246,700 shares $14,137.00 -39.1%0.1%0.1 $2.11 1/31/202411,000 shares $23,650.00 +32.5%0.1%0.2 $2.15 1/15/20248,300 shares $16,600.00 -65.7%0.1%0.2 $2.00 12/31/202324,200 shares $48,158.00 +633.3%0.3%0.5 $1.99 12/15/20233,300 shares $5,115.00 -65.6%0.0%0.1 $1.55 11/30/20239,600 shares $18,048.00 +28.0%0.1%0.3 $1.88 11/15/20237,500 shares $11,586.00 +4.2%0.1%0.4 $1.54 10/31/20237,200 shares $11,808.00 +24.1%0.1%0.6 $1.64 10/15/20235,800 shares $10,904.00 -45.3%0.1%0.4 $1.88 9/30/202310,600 shares $25,652.00 -14.5%0.1%0.7 $2.42 9/15/202312,400 shares $30,132.00 +27.8%0.2%0.8 $2.43 8/31/20239,700 shares $24,444.00 -17.8%0.1%0.6 $2.52Virtually Limitless Energy? (Ad)A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.One company’s discovery could change power forever 8/15/202311,800 shares $29,500.00 +81.5%0.1%0.8 $2.50 7/31/20236,500 shares $15,990.00 -38.7%0.1%0.3 $2.46 7/15/202310,600 shares $28,620.00 +39.5%0.1%0.6 $2.70 6/30/20237,600 shares $22,040.00 +8.6%0.1%0.5 $2.90 6/15/20237,000 shares $22,540.00 -42.2%0.1%0.4 $3.22 5/31/202312,100 shares $36,421.00 +72.9%0.1%0.6 $3.01 5/15/20237,000 shares $20,370.00 -54.6%0.1%0.3 $2.91 4/30/202315,400 shares $39,116.00 +75.0%0.2%0.9 $2.54 4/15/20238,800 shares $21,384.00 +8.6%0.1%0.5 $2.43 3/31/20238,100 shares $19,683.00 -16.5%0.1%0.4 $2.43 3/15/20239,700 shares $22,989.00 -54.9%0.1%0.4 $2.37 2/28/202321,500 shares $54,825.00 +32.7%0.2%0.8 $2.55 2/15/202316,200 shares $40,824.00 -22.1%0.2%0.3 $2.52 1/31/202320,800 shares $59,072.00 -64.0%0.2%0.2 $2.84 1/15/202357,800 shares $167,042.00 -20.4%0.6%0.6 $2.89 12/30/202272,600 shares $174,240.00 -30.1%0.7%0.8 $2.40 12/15/2022103,900 shares $257,672.00 +3.5%1.1%1.1 $2.48 11/30/2022100,400 shares $271,080.00 +666.4%1.0%1.1 $2.70 11/15/202213,100 shares $39,169.00 -34.8%0.1%0.2 $2.99 10/31/202220,100 shares $49,245.00 -33.7%0.2%0.7 $2.45 10/15/202230,300 shares $73,629.00 -14.2%0.3%1.6 $2.43 9/30/202235,300 shares $95,663.00 +18.5%0.4%1.6 $2.71 9/15/202229,800 shares $141,252.00 -18.4%0.3%0.7 $4.74 8/31/202236,500 shares $165,345.00 -5.7%0.4%0.8 $4.53 8/15/202238,700 shares $195,435.00 -14.8%0.4%0.7 $5.05 7/31/202245,400 shares $335,506.00 -25.2%0.5%0.8 $7.39 7/15/202260,700 shares $449,180.00 -23.7%0.7%0.9 $7.40 6/30/202279,600 shares $456,904.00 -79.5%0.9%1.2 $5.74 6/15/2022387,600 shares $2.37 million -4.1%4.2%6 $6.12 5/31/2022404,100 shares $2.02 million +5.0%4.4%8.6 $5.00 5/15/2022384,800 shares $1.86 million +9.6%4.2%8.6 $4.83 4/30/2022351,000 shares $2.14 million +73.3%3.8%8.6 $6.10 4/15/2022202,600 shares $1.28 million +0.5%2.2%5.7 $6.31 3/31/2022201,700 shares $1.62 million +23.4%2.2%5.9 $8.03 3/15/2022163,400 shares $1.30 million +16.8%1.8%5.2 $7.98 2/28/2022139,900 shares $1.06 million +18.1%1.5%3.9 $7.60 2/15/2022118,500 shares $1.03 million +21.8%1.3%3.3 $8.65 1/31/202297,300 shares $956,459.00 +49.0%1.1%2.7 $9.83 1/15/202265,300 shares $593,577.00 -2.1%0.7%1.8 $9.09 12/31/202166,700 shares $775,721.00 -0.3%0.8%1.9 $11.63 12/15/202166,900 shares $602,100.00 -21.9%0.8%2.1 $9.00 11/30/202185,700 shares $880,996.00 -1.7%0.9%2 $10.28 11/15/202187,200 shares $1.11 million -77.7%0.9%1.9 $12.68 10/29/2021390,900 shares $4.54 million -1.7%4.2%6.2 $11.62 10/15/2021397,600 shares $5.02 million -4.7%4.3%6.3 $12.63 9/30/2021417,000 shares $5.67 million -0.9%4.5%6.2 $13.60 9/15/2021420,800 shares $5.84 million -4.9%4.5%5 $13.87 8/31/2021442,400 shares $6.24 million +3.5%4.6%5.7 $14.10 8/13/2021427,600 shares $5.25 million -1.0%4.5%5.8 $12.28 7/30/2021431,800 shares $5.15 million +0.5%4.3%6.2 $11.92Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 7/15/2021429,800 shares $5.98 million -4.7%4.3%7 $13.92 6/30/2021451,000 shares $6.76 million +23.0%4.5%6.2 $14.99 6/15/2021366,600 shares $6.14 million +0.2%3.7%5.3 $16.75 5/28/2021365,800 shares $5.21 million +5.0%3.6%4.8 $14.25 5/14/2021348,400 shares $4.32 million +51.1%3.5%4.5 $12.40 4/30/2021230,600 shares $3.87 million +1.9%3.0%3.1 $16.80 4/15/2021226,400 shares $3.78 million +139.3%3.1%3.3 $16.69 3/31/202194,600 shares $1.65 million -12.6%1.4%1.6 $17.42 3/15/2021108,200 shares $2.17 million -15.3%2.0%2.2 $20.02 2/26/2021127,700 shares $2.46 million +4.1%2.4%3.9 $19.24 2/12/2021122,700 shares $2.25 million +12.1%2.3%4.5 $18.35 1/29/2021109,500 shares $1.78 million -4.7%2.1%4.1 $16.28 1/15/2021114,900 shares $1.69 million -3.2%2.2%5 $14.68 12/31/2020118,700 shares $1.43 million -13.1%2.3%6.3 $12.08 12/15/2020136,600 shares $1.76 million +10.2%2.7%10.9 $12.90 11/30/2020124,000 shares $1.83 million -2.7%2.5%11.8 $14.75 10/30/2020140,200 shares $2.03 million -1.7%2.8%7.4 $14.49 10/15/2020142,600 shares $2.12 million +1.3%2.9%5.7 $14.89 XGN Short Interest - Frequently Asked Questions What is Exagen's current short interest? Short interest is the volume of Exagen shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 60,800 shares of XGN short. 0.66% of Exagen's shares are currently sold short. Learn More on Exagen's current short interest. Which institutional investors are shorting Exagen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exagen: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Exagen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.66% of Exagen's floating shares are currently sold short. Is Exagen's short interest increasing or decreasing? Exagen saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 60,800 shares, an increase of 31.6% from the previous total of 46,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Exagen's float size? Exagen currently has issued a total of 17,898,000 shares. Some of Exagen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Exagen currently has a public float of 9,170,000 shares. How does Exagen's short interest compare to its competitors? 0.66% of Exagen's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Exagen: Celcuity Inc. (6.40%), InnovAge Holding Corp. (1.30%), Enhabit, Inc. (3.29%), Personalis, Inc. (6.51%), Viemed Healthcare, Inc. (0.99%), LifeMD, Inc. (17.45%), DocGo Inc. (7.59%), The Oncology Institute, Inc. (4.15%), AirSculpt Technologies, Inc. (33.39%), Agape ATP Co. (1.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Exagen stock? Short selling XGN is an investing strategy that aims to generate trading profit from Exagen as its price is falling. XGN shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exagen? A short squeeze for Exagen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XGN, which in turn drives the price of the stock up even further. How often is Exagen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XGN, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Celcuity Short Interest InnovAge Short Interest Enhabit Short Interest Personalis Short Interest Viemed Healthcare Short Interest LifeMD Short Interest DocGo Short Interest Oncology Institute Short Interest AirSculpt Technologies Short Interest Agape ATP Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XGN) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XGN Stock Free XGN Stock Alerts